Brief: Dyne Therapeutics Receives FDA Fast Track Designation For Dyne-101

Dyne Therapeutics

21/01/2025 12:43

Jan 21 (Reuters) - Dyne Therapeutics Inc  DYN.O :
    * DYNE THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR
DYNE-101 FOR THE TREATMENT OF MYOTONIC DYSTROPHY TYPE 1
    * DYNE THERAPEUTICS INC - TO SUBMIT FOR U.S. ACCELERATED
APPROVAL
IN H1 2026

Source text:  ID:nGNX9m9Xf2 
Further company coverage:  DYN.O